首页> 外文期刊>The pharmaceutical journal >Current and future options for the management of heart failure
【24h】

Current and future options for the management of heart failure

机译:当前和未来的心力衰竭治疗选择

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic heart failure is an increasing problem worldwide. There are around 900,000 people with heart failure in the UK and almost as many with damaged hearts but without any symptoms of heart failure. Heart failure is a complex syndrome of symptoms and signs. If left untreated, it has a poor prognosis, but mortality and morbidity can be greatly improved by early, targeted treatment.The most common causes of chronic heart failure in the UK are coronary heart disease and hypertension, with many patients having had a myocardial infarction in the past. Associated risk factors, such as an ageing population, increases in the rates of diabetes mellitus and hyperlipidaemia, and smoking, have also contributed to the increasing prevalence of heart failure in the UK.
机译:慢性心力衰竭是世界范围内日益严重的问题。在英国,大约有90万人患有心力衰竭,而心脏受损但几乎没有心力衰竭症状的人数几乎与之相同。心力衰竭是一种复杂的症状和体征。如果不及时治疗,其预后较差,但通过早期针对性治疗可以大大提高死亡率和发病率。在英国,慢性心力衰竭的最常见原因是冠心病和高血压,许多患者患有心肌梗塞在过去。相关的危险因素,例如人口老龄化,糖尿病和高脂血症的发生率增加以及吸烟,也导致英国心力衰竭患病率上升。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号